Freeze-Dried Formula May Block HIV Virus in Breast Milk By Serena Gordon, HealthDay Reporter THURSDAY, July 2 (HealthDay News) -- In developing countries where breast-feeding is a necessity, and HIV is rampant, the risk of disease transmission through breast milk might be reduced if infants were...
Outcome of Single-Bundle Versus Double-Bundle Reconstruction of the Anterior Cruciate Ligament: A Meta-Analysi From * Taos Orthopaedic Institute Research Foundation, Taos, New Mexico, and Smith & Nephew, Andover, Massachusetts Address correspondence to James H.Lubowitz, Taos Orthopaedic Institute Research Foundation, 1219-A...
::: Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dep SOUTH EASTON, Mass., June 24 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc.(NASDAQ:PBIO) ('PBI' and 'the Company') today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) Grant (2R44GM079059-02)...
Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-depende SOUTH EASTON, Mass., June 24 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc.(Nasdaq: PBIO - News; 'PBI' and 'the Company') today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) Grant ...
Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-depende /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc.('PBI' and 'the Company') today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) Grant (2R44GM079059-02) from the National Institutes of Health ...
Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-depende SOUTH EASTON, Mass., June 24 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc.(Nasdaq: PBIO) ('PBI' and 'the Company') today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) Grant (2R44GM079059-02...
Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-depende SOUTH EASTON, Mass., June 24 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc.(Nasdaq: PBIO - News; 'PBI' and 'the Company') today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) Grant ...
Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-depende SOUTH EASTON, Mass., June 24 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc.(Nasdaq: PBIO) ('PBI' and 'the Company') today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) Grant (2R44GM079059-02...
Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-depende SOUTH EASTON, Mass., June 24 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc.(Nasdaq: PBIO) ('PBI' and 'the Company') today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) Grant (2R44GM079059-02...
Tao Formulations Announces the Official Launch of Tao Harmony - Menopause Relief Formula Tao Formulations announces the official launch of Tao Harmony - Menopause Relief Formula, at the Internal Medicine 2008 conference in Washington DC.This revolutionary product is the culmination of years of research to develop...
Nurses' Notes - Cancer survivors will face a new normal life Thousands of Americans are living disease-free after cancer treatment.But not all cancer survivors live without side effects from the treatment.
Treatments for cancer can include surgery, chemotherapy and radiation.
Side effects...
Drug Delivery to the Retina Using Intravitreal Aerosolized Nanoparticles TIMOTHY W.OLSEN, MD Targeted drug delivery to the retina is an active area of research.
A key goal is to provide local drug therapy to the retina while minimizing the systemic levels and systemic toxicity.
The best way to understand...
Women's meet ends with cancer pledge HA NOI The Global Summit of Women in Ha Noi came to a close Saturday with Viet Nams pledge to join in the global fight against cervical cancer and other cancers affecting women.The commitment was made by minister of health Nguyen Quoc...
Bayer's, Johnson & Johnson's Xarelto reduces risk of VTE compared with Lovenox Results from a Phase III study showed that patients who took Johnson & Johnson's and Bayer's anticoagulant Xarelto (rivaroxaban) following total knee replacement surgery were less likely to develop venous thromboembolisms (VTE) than...
Deutsche Bank analyst expects J&J's blood-clot drug to be a blockbuster NEW YORK (AP) - The anti-bloodclotting drug Rivaroxaban could help Johnson & Johnson fight off anticipated revenue losses from generic competition, according to a Deutsche Bank-North America analyst.The drug, which treats blood clots...
Analyst: J&J blood-clot drug poised for success NEW YORK - The anti-bloodclotting drug Rivaroxaban could help Johnson & Johnson fight off anticipated revenue losses from generic competition, according to a Deutsche Bank-North America analyst.The drug, which treats blood clots after...
Analyst: J&J blood-clot drug poised for success The anti-bloodclotting drug Rivaroxaban could help Johnson & Johnson fight off anticipated revenue losses from generic competition, according to a Deutsche Bank-North America analyst.The drug, which treats blood clots after orthopedic...
Analyst: J&J blood-clot drug poised for success NEW YORK (AP) - The anti-bloodclotting drug Rivaroxaban could help Johnson & Johnson fight off anticipated revenue losses from generic competition, according to a Deutsche Bank-North America analyst.The drug, which treats blood clots...
